Form SC 13G TG THERAPEUTICS, INC. Filed by: FMR LLC

Go back to Form SC 13G TG THERAPEUTICS, INC. Filed by: FMR LLC

TG Therapeutics (TGTX) Continuing to Drive on All Cylinders; Roth Affirms 'Focus Pick' Rating

August 10, 2015 11:27 AM EDT

Roth Capital reaffirms TG Therapeutics, Inc. (Nasdaq: TGTX) with a Focus Pick rating and $33 price target following... More